First-line R-CVP vs R-CHOP Induction Immunochemotherapy for Indolent Lymphoma and R Maintenance.
Status:
Completed
Trial end date:
2017-06-25
Target enrollment:
Participant gender:
Summary
Evaluation of event free survival (EFS) of patients treated with the study chemotherapy
induction program: R-CHOP compared to the standard R-CVP regimen and response rates, time to
best response, PFS, OS, neutropenic fever rate, infection rate, change in Ig levels, change
in lymphocyte subpopulations counts in previously untreated indolent lymphoma patients in
need of systemic treatment.